Investors News Year 2022 2021 2020 2019 2018 2022 BioGraphene April 19 2022 2022 BioGraphene April 19 2022 BioGraphene Appoints Dr. Daehee Kang as Medical Advisor Read More 2022 BioGraphene March 31 2022 2022 BioGraphene March 31 2022 BioGraphene Presented at the 10th Annual Neurodegenerative Drug Development Summit Read More 2022 BioGraphene March 22 2022 2022 BioGraphene March 22 2022 BioGraphene Signs Patent License Agreement with Seoul National University and Johns Hopkins University Read More 2022 BioGraphene January 03 2022 2022 BioGraphene January 03 2022 BioGraphene Signs Collaboration Agreement with Dr. Paulina Ordonez for BGN-112’s Pharmacodynamic Study Read More Newer Posts
2022 BioGraphene April 19 2022 2022 BioGraphene April 19 2022 BioGraphene Appoints Dr. Daehee Kang as Medical Advisor Read More
2022 BioGraphene March 31 2022 2022 BioGraphene March 31 2022 BioGraphene Presented at the 10th Annual Neurodegenerative Drug Development Summit Read More
2022 BioGraphene March 22 2022 2022 BioGraphene March 22 2022 BioGraphene Signs Patent License Agreement with Seoul National University and Johns Hopkins University Read More
2022 BioGraphene January 03 2022 2022 BioGraphene January 03 2022 BioGraphene Signs Collaboration Agreement with Dr. Paulina Ordonez for BGN-112’s Pharmacodynamic Study Read More
